FGIN-1-X: A series of novel specific and efficacious ligands for the peripheral benzodiazepine receptor

Neurosteroid Effects in the Central Nervous System: The Role of the GABA-A Receptor

Volumn , Issue , 2003, Pages 197-218

  Skowronski Lutz, Ethan M ^a   Bitran, Daniel ^a  

^a Religious Studies Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860072296     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (135)

1. Romeo, E., Auta, J., Kozikowski, A.P., Ma, D., Papadopoulos, V., Puia, G., Costa, E., and Guidotti, A., 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR), J. Pharmacol. Exp. Ther., 262, 971-978, 1992.
2. Kozikowski, A.P., Ma, D., Brewer, J., Sun, S., Costa, E., Romeo, E., and Guidotti, A., Chemistry, binding affinities, and behavioral properties of a new class of antineophobic mitochondrial DBI receptor complex (mDRC) ligands, J. Med. Chem., 36, 2908-2920, 1993.
3. Liao, Y., Kozikowski, A.P., Guidotti, A., and Costa, E., Synthesis and pharmacological evaluation of benzofuran-acetamides as “antineophobic” mitochondrial DBI receptor complex ligands, Bioorg. Med. Chem. Lett., 8, 2099-2102, 1998.
4. Guillon, J., Boulouard, M., Lelong, V., Dallemagne, P., Rault, S., and Jarry, C., Synthesis and preliminary behavioral evaluation of mice of new 3-aryl-3-pyrol-1- ylpropanimides, analogues of FGIN-1-27 and FGIN-1-43, Pharmacy Pharmacol., 53, 1561-1568, 2001.
5. A receptor structure and function, J. Biol. Chem., 267, 16747-16750, 1992.
6. Mohler, H. and Okada, T., Benzodiazepine receptors: demonstration in the central nervous system, Science, 198, 849-851, 1977.
7. Squires, R. and Braestrup, C., Benzodiazepine receptors in rat brain, Nature, 266, 732-734, 1977.
8. Tallman, J.F., Paul, S.M., Skolnick, P., and Gallager, D.W., Receptors for the age of anxiety: pharmacology of the benzodiazepines, Science, 207, 274-281, 1980.
9. Paul, S.M., Marangos, P.J., and Skolnick, P., The benzodiazepine-GABA-chloride ionophore receptor complex: common site of minor tranquilizer action, Biol. Psychiatry, 16, 213-229, 1981.
10. 3H]diazepam binding, Proc. Natl. Acad. Sci. U.S.A., 74, 3805-3809, 1977.
11. 3H] Ro 5-4864, Mol. Pharmacol., 22, 26-32, 1982.
12. Verma, A. and Snyder, S.H., Peripheral type benzodiazepine receptors, Annu. Rev. Pharmacol. Toxicol., 29, 307-322, 1989.
13. Anholt, R.R.H., Pedersen, P.L., De Souza, E.B., and Snyder, S.H., The peripheraltype benzodiazepine receptor: localization to the mitochondrial outer membrane, J. Biol. Chem., 261, 576-583, 1986.
14. Papadopoulos, V., Berkovich, A., Krueger, K.E., Costa, E., and Guidotti, A., Diazepam binding inhibitor (DBI) and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors, Endocrinology, 129, 1481-1488, 1991.
15. Sprengel, R., Werner, P., Seeburg, P.H., Mukhin, A.G., Santi, M.R., Grayson, D.R., Guidotti, A., and Krueger, K.E., Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor, J. Biol. Chem., 264, 20415-20421, 1989.
16. Papadopoulos, V., Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function, Endocr. Rev., 14, 222-240, 1993.
17. Mukhin, A.G., Papadopoulos, V., Costa, E., and Krueger, K.E., Mitochondrial benzodiazepine receptors regulate steroid biosynthesis, Proc. Natl. Acad. Sci. U.S.A., 86, 9813-9816, 1989.
18. Cascio, C., Guarneri, P., Li, H., Brown, R.C., Amri, H., Boujrad, N., Kotoula, M., Vidic, B., Drieu, K., and Papadopoulos, V., Peripheral-type benzodiazepine receptor: role in the regulation of steroid and neurosteroid biosynthesis, in Neurosteroids: A New Regulatory Function in the Nervous System, Balieu, E.-E., Robel, P., and Schumacher, M., Eds., Humana Press, Totowa, NJ, 1999, pp. 75-96.
19. Brown, R.C., Cascio, C., and Papadopoulos, V., Neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and amyloid peptide, J. Neurochem., 74, 847-859, 2000.
20. Hardwick, M., Fertikh, D., Culty, M., Li, H., Vidic, B., and Papadopoulos, V., Peripheral- type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBRmediated cell proliferation and nuclear transport of cholesterol, Cancer Res., 59, 831-842, 1999.
21. Garnier, M., Boujrad, N., Oke, B.O., Brown, A.S., Riond, J., Ferrara, P., Shoyab, M., Suarez-Ouain, C.A., and Papadopoulos, V., Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms, Endocrinology, 132, 444-458, 1993.
22. Oke, B.O., Suarez-Ouain, C.A., Riond, J., Ferrara, P., and Papadopoulos, V., Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex, Mol. Cell. Endocrinol., 87, R1-R6, 1992.
23. Drugan, R.C., Peripheral benzodiazepine receptors: molecular pharmacology to possible physiological significance in stress-induced hypertension, Clin. Neuropharmacol., 19, 475-496, 1996.
24. Hirsch, J.D., Beyer, C.F., Malkowitz, L., Beer, B., and Blume, A.J., Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control, Mol. Pharmacol., 35, 157-163, 1989.
25. Moreno-Sanchez, R., Hogue, B.A., Bravo, C., Newman, A.H., Basile, A.S., and Chiang, P.K., Inhibition of substrate oxidation in mitochondria by the peripheral-type benzodiazepine receptor ligand AHN 086, Biochem. Pharmacol., 41, 1479-1484, 1991.
26. Kuhlmann, A.C. and Guilarter, T.R., Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethylin neurotoxicity, J. Neurochem., 74, 1694-1704, 2000.
27. 3H] RO5-4864 to benzodiazepine binding sites in rat cerebral cortex, Eur. J. Pharmacol., 71, 173-175, 1981.
28. Guilarte, T.R., Kuhlmann, A.G., O’Callaghan, J.P., and Miceli, R.C., Enhanced expression of peripheral benzodiazepine receptors in trimethylin-exposed rat brain: a biomarker of neurotoxicity, Neurotoxicology, 16, 441-450, 1995.
29. Torres, S.R., Frode, T.S., Nardi, G.M., Vita, N., Reeb, R., Ferrara, P., Ribeiro-do-Valle, R.M., and Farges, R.C., Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation, Eur. J. Pharmacol., 408, 199-211, 2000.
30. Lacor, P., Gandolfo, P., Tonon, M.C., Brault, E., Dalibert, I., Schumacher, M., Benavides, J., and Ferzaz, B., Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role of PBR in neurosteroidogenesis, Brain Res., 516, 295-303, 1999.
31. Marchetti, P., Trincavelli, L., Giannarelli, R., Giusti, L., Coppelli, A., Martini, C., Navalesi, R., and Lucacchini, A., Characterization of peripheral benzodiazepine receptors in purified large mammal pancreatic islets, Biochem. Pharmacol., 51, 1437-1442, 1996.
32. Mestre, M., Carriot, T., Berlin, C., Uzan, A., Renault, C., Dubroeucq, M.C., Gueremy, C., and Le Fur, G., Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in guinea pig heart preparation, Life Sci., 35, 953-962, 1984.
33. Bisserbe, J.C., Patel, J., and Eskay, R.L., Evidence that the peripheral-type benzodiezapine receptor ligand Ro 5-4864 inhibits beta-endorphin release from AtT-20 cells by blockade of voltage-dependent calcium channels, J. Neurochem., 47, 1419-1424, 1986.
34. Basile, A.S., Lueddens, H.W., and Skolnick, P., Regulation of renal peripheral benzodiazepine receptors by anion transport inhibitors, Life Sci., 42, 715-726, 1988.
35. Basile, A.S., Bolger, G.T., Lueddens, H.W.M., and Skolnick, P., Electrophysiological actions of Ro 5-4864 on cerebellar Purkinje neurons: evidence for peripheral benzodiazepine receptor-mediated depression, J. Pharmacol. Exp. Ther., 248, 463-469, 1989.
36. Leuddens, H.W. and Skolnick, P., ‘Peripheral-type’ benzodiazepine receptors in the kidney: regulation of radioligand binding by anions and DIDS, Eur. J. Pharmacol., 133, 205-214, 1987.
37. Bono, F., Lamarche, I., Prabonnaud, V., Le Fur, G., and Herbert, J.M., Peripheral benzodiazepine receptor agonists exhibit potent antiapoptic activities, Biochem. Biophys. Res. Commun., 265, 457-461, 1999.
38. Pastorino, J.G., Simbula, G., Yamamoto, K., Glascott, P.A., Jr., Rothman, R.J., and Farber, J.L., The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition, J. Biol. Chem., 271, 29792-29798, 1996.
39. Zonov, D.B., Mitochondrial damage as a source of diseases and aging: a strategy of how to fight these, Biochem. Biophys. Acta, 1275, 10-15, 1996.
40. Fennell, D.A., Corbo, M., Pallaska, A., and Cotter, F.E., Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamides PK 11195 involves de novo generation of reactive oxygen species, Br. J. Cancer, 84, 1397-1404, 2001.
41. Gunter, T.E., Gunter, K.K., Sheu, S., and Gavin, C.E., Mitochondrial calcium transport: physiological and pathological relevance, Am. J. Physiol., 267, C313-C319, 1994.
42. Zoratti, M. and Szabo, I., The mitochondrial permeability transition, Biochim. Biophys. Acta, 1241, 139-176, 1995.
43. Korneyev, A., Pan, B.S., Polo, A., Romeo, E., Guidotti, A., and Costa, E., Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo, J. Neurochem., 61, 1515-1524, 1993.
44. Rago, L., Saano, V., Auvinen, T., Adojaan, A., Holma, R., and Airaksinen, M.M., The effect of chronic treatment with peripheral benzodiazepine receptor ligands on behavior and GABAA/benzodiazepine receptors in rat, Naunym Schmiedeberg Arch. Pharmacol., 346, 432-436, 1992.
45. Benavides, J.J., Guilloux, F., Allam, D.E., Uzan, A., Mizoule, J., Renault, C., Dubroeucq, C., Gueremy, C., and Le Fur, G., Opposite effects of an agonist, Ro 5-4864, and an antagonist PK 11195 of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA-2J mice, Life Sci., 34, 2613-2620, 1984.
46. Pellow, S. and File, S.E., Behavioral actions of Ro 5-4864: a peripheral-type benzodiazepine? Life Sci., 35, 229-240, 1984.
47. 3H] PK 14105, Eur. J. Pharmacol., 148, 187-193, 1988.
48. Puia, G., Santi, M.R., Vicini, S., Pritchett, D.B., Seeburg, P.H., and Costa, E., Differences in the negative allosteric modulation of γ-aminobutyric acid receptors elicited by 4'-chlordiazepam and by β -carboline-3-carboxylate ester: a study with natural and reconstituted receptors, Proc. Natl. Acad. Sci. U.S.A., 86, 7275-7279, 1989.
49. Puia, G., Vicini, S., Seeburg, P.H., and Costa, E., Influence of recombinant γ-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of γ-aminobutyric acid-gated Cl- currents, Mol. Pharmacol., 39, 691-696, 1991.
50. Kozikowski, A.P., Kotoula, M., Ma, D., Boujrad, N., Tuckmantel, W., and Papadopoulos, V., Synthesis and biology of a 7-nitro-2,1,3-benzoaxdiazol-4-yl derivative of 2- phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptor, J. Med. Chem., 40, 2435-2439, 1997.
51. File, S.E. and Pellow, S., The effects of PK 11195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress, Pharmacol. Biochem. Behav., 23, 737-741, 1985.
52. Kunert-Radek, J., Stepien, H., and Pawlikowski, M., Inhibition of rat pituitary tumor cell proliferation by benzodiazepines in vitro, Neuroendocrinology, 59, 92-96, 1994.
53. Pawlikowski, M., Kunert-Radek, J., Radek, A., and Stepien, H., Inhibition of cell proliferation of human gliomas by benzodiazepines in vitro, Acta Neurol. Scand., 77, 231-233, 1988.
54. Calogero, A.E., Kamilaris, T.C., Bernardini, R., Johnson, E.O., Chrousos, G.P., and Gold, P.W., Effects of peripheral benzodiazepine receptor ligands on hypothalamicpituitary- adrenal axis function in the rat, J. Pharmacol. Exp. Ther., 253, 729-737, 1990.
55. Maaser, K., Hopfner, M., Jansen, A., Weisinger, G., Gavish, M., Kozikowski, A.P., Weizman, A., Carayon, P., Riecken, E.O., Zeitz, M., and Scherubl, H., Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells, Br. J. Cancer, 85, 1771-1780, 2001.
56. 3H] PK 11195 and autoradiographic localization, Arch. Int. Pharmacodyn. Ther., 266, 38-49, 1983.
57. DeSouza, E.B., Anholt, R.R., Murphy, K.M., Snyder, S.H., and Kuhar, M.J., Peripheral- type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis, Endocrinology, 116, 567-573, 1985.
58. Davies, L.P. and Huston, V., Peripheral benzodiazepine binding sites in heart and their interaction with dipyridamole, Eur. J. Pharmacol., 73, 209-211, 1981.
59. French, J.F. and Matlib, M.A., Identification of a high-affinity peripheral-type benzodiazepine binding site in rat aortic smooth muscle membranes, J. Pharmacol. Exp. Ther., 247, 23-28, 1988.
60. Wang, J.K., Morgan, J.I., and Spector, S., Benzodiazepines that bind at peripheral sites inhibit cell proliferation, Proc. Natl. Acad. Sci. U.S.A., 81, 753-756, 1984.
61. Olson, J.M., Ciliax, B.J., Mancini, W.R., and Young, A.B., Presence of peripheraltype benzodiazepine binding sites on human erythrocyte membranes, Eur. J. Pharmacol., 152, 47-53, 1988.
62. Ruff, M.R., Pert, C.B., Weber, R.J., Wahl, L.M., Wahl, S.M., and Paul, S.M., Benzodiazepine receptor-mediated chemotaxis of human monocytes, Science, 229, 1281-1283, 1985.
63. Zavala, F., Haumont, J., and Lenfant, M., Interaction of benzodiazepines with mouse macrophages, Eur. J. Pharmacol., 106, 561-566, 1984.
64. 3H] PK 14105, J. Pharmacol. Exp. Ther., 249, 333-339, 1989.
65. Drugan, R.C. and Holmes, P.V., Central and peripheral benzodiazepine receptors: involvement in an organism’s response to physical and psychological stress, Neurosci. Biobehav. Rev., 15, 277-298, 1991.
66. 3H] PK 11195: anatomical and subcellular distribution, Brain Res. Bull., 18, 49-61, 1987.
67. 3H] PK 11195, an isoquinoline carboximide derivative: kinetic studies and autoradiographic localization, J. Neurochem., 41, 1744-1750, 1983.
68. 3H] Ro 5-4864 in primary cultures of astrocytes, Brain Res., 341, 41-49, 1985.
69. Basile, A.S. and Skolnick, P., Subcellular localization of “peripheral-type” binding sites for benzodiazepines in rat brain, J. Neurochem., 46, 305-308, 1986.
70. Viliger, J., Specific [3H] Ro 5-4864 binding to rat spinal cord membranes: evidence for peripheral-type benzodiazepine recognition sites, Neurosci. Lett., 46, 267-270, 1984.
71. Hall, P.F., Cellular organization of steroidogenesis, Int. Rev. Cytol., 86, 53-95, 1984.
72. Besman, M.J., Yanagibashi, K., Lee, T., Kawamura, M., Hall, P.F., and Shiveley, J.E., Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor, Proc. Natl. Acad. Sci. U.S.A., 86, 4897-4901, 1989.
73. Papadopoulos, V., Amri, H., Boujard, N., Cascio, C., Culty, M., Garnier, M., Hardwick, M., Li, H., Vidic, B., Brown, A.S., Reversa, J.L., Bernassau, J.M., and Drieu, K., Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis, Steroids, 62, 21-28, 1997.
74. Yanagibashi, K., Ohno, Y., Nakamichi, N., Matsui, T., Hayashida, K., Takamura, M., Yamada, K., Tou, S., and Kawamura, M., Peripheral-type benzodiazepine receptors are involved in the regulation of cholesterol side chain cleavage in adrenocortical mitochondria, J. Biochem. (Tokyo), 106, 1026-1029, 1989.
75. Krueger, K.E. and Papadopoulos, V., Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells, J. Biol. Chem., 265, 15015-15022, 1990.
76. Yanagibashi, K., Ohno, Y., Nakamichi, N., Matsui, T., Hayashida, K., Takamura, M., Yamada, K., Tou, S., and Kawamura, M., Diazepam potentiates the corticodogenic response of bovine adrenal fasciculata cells to dibutyryl cyclic AMP, Jpn. J. Pharmacol., 51, 347-355, 1989.
77. Morrow, A.L., Suzdak, P.D., and Paul, S.M., Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion influx with nanomolar potency, Eur. J. Pharmacol., 142, 483-485, 1987.
78. Majewska, M.D. and Vaupel, D.B., Steroid control of uterine motility via gammaaminobutyric acidA receptors in the rabbit: a novel mechanism? J. Endocrinol., 131, 427-434, 1991.
79. A receptor, Horm. Behav., 28, 537-544, 1994.
80. Paul, S.M. and Purdy, R.H., Neuroactive steroids, FASEB J., 6, 2311-2322, 1992.
81. Barnea, A., Hajibeigi, A., Trant, J.M., and Mason, J.I., Expression of steroid metabolizing enzymes by aggregating fetal brain cells in culture: a model for developmental regulation of the progesterone 5alpha-reductase pathway, Endocrinology, 127, 500-502, 1990.
82. Melacagni, R.C., Celotti, F., Ballabio, M., Castano, P., Massarelli, R., Poletti, A., and Martini, L., 5α-Reductase activity in isolated and cultured neuronal and glial cells of the rat, Brain Res., 516, 229-236, 1990.
83. Purdy, R.H., Morrow, A.L., Blinn, J.R., and Paul, S.M., Synthesis, metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABA-receptormediated chloride ion uptake in rat cerebral cortical synaptoneurosomes, J. Med. Chem., 33, 1572-1581, 1990.
84. Bitran, D., Foley, M., Audette, D., Leslie, N., and Frye, C.A., Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat, Psychopharmacology, 151, 64-71, 2000.
85. Romeo, E., Cavallaro, S., Korneyev, A., Kozikowski, A.P., Ma, D., Polo, A., Costa, E., and Guidotti, A., Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex, J. Pharmacol. Exp. Ther., 267, 462-471, 1993.
86. Snyder, M. and Antwerpen, R.V., Evidence for a diazepam-binding inhibitor (DBI) benzodiazepine receptor-like mechanism in ecdysteroidogenesis by the insect prothoracic gland, Cell Tissue Res., 294, 161-168, 1998.
87. Cutolo, M., Seriolo, B., Villagio, B., Pizzorni, C., Craviotto, C., and Sulli, A., Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis, Ann. N.Y. Acad. Sci., 966, 131-142, 2002.
88. Castagnetta, L., Granata, O.M., Traina, A., Cocciadiferro, L., Saetta, A., Stefano, R., Cutolo, M., and Carruba, G., A role for sex steroids in autoimmune diseases: a working hypothesis and supporting data, Ann. N.Y. Acad. Sci., 966, 193-203, 2002.
89. Goldstein, J.S. and Sites, C.K., Selective modulation of sex steroids, Ageing Res. Rev., 1, 17-28, 2002.
90. Pastorino, J.G., Snyder, J.W., Serroni, A., Hoek, J.B., and Farber, J.L., Cyclosporin and carnitine prevent anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition, J. Biol. Chem., 268, 13791-13798, 1993.
91. Pastorino, J.G., Snyder, J.W., Hoek, J.B., and Farber, J.L., Ca2+ depletion prevents anoxic death of hepatocytes by inhibiting mitochondrial permeability transition, Am. J. Physiol., 268, C676-C685, 1995.
92. Snyder, J.W., Pastorino, J.G., Attie, A., and Farber, J.L., Protection by cyclosporin A of cultured hepatocytes from the toxic consequences of the loss of mitochondrial energization produced by 1-methyl-4-phenylpyridinium, Biochem. Pharmacol., 44, 833-835, 1992.
93. Cornu, P., Benavides, J., Scatton, B., Hauw, J.J., and Philippson, J., Increase in omega-3 tumors: a quantitative autoradiographic study, Acta Neurochim., 119, 146-152, 1992.
94. Miettinen, H., Kononen, J., Haapasalo, H., Helen, P., Sallinen, P., Harjuntausta, T., Helin, H., and Alho, H., Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation, Cancer Res., 15, 2691-2695, 1995.
95. Starosta-Rubenstein, S., Ciliax, B.J., Penney, J.B., McKeever, P., and Young, A.B., Imaging of a glioma using peripheral benzodiazepine receptor ligands, Proc. Natl. Acad. Sci. U.S.A., 84, 891-895, 1987.
96. Zisterer, D.M. and Williams, D.C., Peripheral-type benzodiazepine receptors, Gen. Pharmacol., 29, 305-314, 1997.
97. Neary, J.T., Jorgensen, S.L., Oracion, A.M., Bruce, J.H., and Norenburg, M.D., Inhibition of growth factor-induced DNA synthesis in astrocytes by ligands of peripheral- type benzodiazepine receptors, Brain Res., 675, 27-30, 1995.
98. Landau, M., Weizman, A., Zoref-Shani, E., Beery, E., Wasseman, L., Landau, O., Gavish, M., Brenner, S., and Nordenberg, J., Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells, Biochem. Pharmacol., 56, 1029-1034, 1998.
99. Carmel, I., Fares, F.A., Leschiner, S., Scherubl, H., Weisinger, G., and Gavish, M., Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line, Biochem. Pharmacol., 58, 273-278, 1999.
100. Beinlich, A., Strohmeir, R., Kaufmann, M., and Kuhl, H., Specific binding of benzodiazepines to human breast cancer cell lines, Life Sci., 65, 2099-2108, 1999.
101. Ikezaki, K. and Black, K.L., Stimulation of cell growth and DNA synthesis by peripheral benzodiazepine receptor agonist, Cancer Lett., 49, 115-120, 1990.
102. Nunez, G., Benedict, M.A., Hu, Y., and Inohara, N., Caspases: the proteases of the apoptotic pathway, Oncogene, 17, 3237-3245, 1998.
103. Camins, A., Diez-Fernandez, C., Fujadas, E., Camarasa, J., and Escubedo, E., A new aspect of the antiproliferative action of peripheral-type benzodiazepine receptor ligands, Eur. J. Pharmacol., 272, 289-292, 1995.
104. Reddy, D.S. and Kulkarni, S.K., Reversal of benzodiazepine inverse agonist FG 7142- induced anxiety syndrome by neurosteroids in mice, Methods Find. Exp. Clin. Pharmacol., 19, 665-681, 1997.
105. Reddy, D.S. and Kulkarni, S.K., Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice, Brain Res., 752, 61-71, 1997.
106. Baulieu, E.-E., Neurosteroids: a novel function of the brain, Psychoneuroendocrinology, 23, 963-987, 1998.
107. Auta, J., Romeo, E., Kozikowski, A., Ma, D., Costa, E., and Guidotti, A., Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives, J. Pharmacol. Exp. Ther., 265, 649-656, 1993.
108. Costa, E., Auta, J., Guidotti, A., Korneyev, A., and Romeo, E., The pharmacology of neurosteroidogenesis, J. Steroid Biochem., 49, 385-389, 1994.
109. Dong, E., Matsumoto, K., and Watanabe, H., Involvement of peripheral type of benzodiazepine receptor in social isolation stress-induced decrease in pentobarbital sleep in mice, Life Sci., 65, 1561-1568, 1999.
110. Tsuda, M., Suzuki, T., and Misawa, M., Subsensitivity to mitochondrial diazepam binding inhibitor receptor agonist FGIN 1-27-induced antiseizure effect in diazepamwithdrawn mice, Life Sci., 62, PL213-PL217, 1998.
111. Uzanov, V., Sheline, Y., Davis, J.M., Rasmusson, A., Uzanov, D.P., Costa, E., and Guidotti, A., Increase in cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine, Proc. Natl. Acad. Sci. U.S.A., 95, 3239-3244, 1998.
112. Strohle, A., Romeo, E., Hermann, B., Pasini, A., Spalletta, G., di Michele, F., Holsboer, F., and Rupprecht, R., Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery, Biol. Psychiatry, 45, 274-277, 1999.
113. Romeo, E., Strohle, A., Spalletta, G., di Michele, F., Hermann, B., Holsboer, F., Pasini, A., and Rupprecht, R., Effects of antidepressant treatment on neuroactive steroids in major depression, Am. J. Psychiatry, 155, 910-913, 1998.
114. Khisti, R.T. and Chopde, C.T., Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice, Brain Res., 865, 291-300, 2000.
115. Khisti, R.H., Chopde, C.T., and Jain, S.P., Antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice forced swim test, Pharmacol. Biochem. Behav., 67, 137-143, 2000.
116. Hirani, K., Khisti, R.H., and Chopde, C.T., Behavioral action of ethanol in Porsolt’s forced swim test: modulation by 3alpha-hydroxy-5alpha-pregnan-20-one, Neuropharmacology, 43, 1339-1350, 2003.
117. Markowski, M., Ungeheuer, M., Bitran, D., and Locurto, C., Memory-enhancing effects of DHEAS in aged mice on a win-shift water escape task, Physiol. Behav., 72, 521-525, 2001.
118. Flood, J.F. and Roberts, E., Dehydroepiandrosterone sulfate improves memory in aging mice, Brain Res., 448, 178-181, 1988.
119. Flood, J.F., Smith, G.E., and Roberts, E., Dehydroepiandrosterone and its sulfate enhance memory retention in mice, Brain Res., 447, 269-278, 1988.
120. Flood, J., Morley, J., and Roberts, E., Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it, Neurobiology, 89, 1567-1572, 1992.
121. Da Cunha, C., Huang, C.H., Walz, R., Dias, M., Koya, R., Bianchin, M., Pereira, M.E., Izquierdo, I., and Medina, J.H., Memory facilitation by post-training intraperitoneal, intracerebroventricular, and intra-amygdala injection of Ro 5-4864, Brain Res., 554, 133-136, 1991.
122. Roberts, E. and Fitten, L.J., Serum steroid levels in two old men with Alzheimer’s disease (AD), before, during, and after oral administration of dehydroepiandrosterone (DHA): pregnenolone synthesis may be rate limiting in aging, in The Biological Role of Dehydroepiandrosterone (DHEA), Kalimi, M. and Regelson, W., Eds., De Gruyter, Berlin, 1990, pp. 43-63.
123. Edgar, P.F., Schonberger, S.J., Dean, B., Faull, R.L., Kydd, R., and Cooper, G.J., A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer’s disease individuals, Mol. Psychiatry, 4, 173-178, 1999.
124. Freeman, F.M. and Young, I.G., The mitochondrial benzodiazepine receptor and avoidance learning in the day-old chick, Pharmacol. Biochem. Behav., 67, 355-362, 2000.
125. Romeo, E., Cheney, D.L., Zivkovic, I., Costa, E., and Guidotti, A., Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizolcipine amnesia: putative role for allopregnanolone, J. Pharmacol. Exp. Ther., 270, 89-96, 1994.
126. Mandhane, S.N., Khisti, R.T., and Chopde, C.T., Adenosinergic modulation of 3α- hydroxy-5α-pregnan-20-one induced catalepsy in mice, Psychopharmacology, 144, 398-404, 1999.
127. Khisti, R.T., Mandhane, S.N., and Chopde, C.T., The neurosteroid 3α-hydroxy-5α- pregnan-20-one induces catalepsy in mice, Neurosci. Lett., 251, 85-88, 1998.
128. Deshpande, L.S., Khisti, R.T., and Chopde, C.T., Cataleptic effect of neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice: modulation by serotonergic agents, Brain Res., 898, 13-26, 2001.
129. Uzanov, D.P., Cooper, T.B., Costa, E., and Guidotti, A., Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography, Proc. Natl. Acad. Sci. U.S.A., 93, 12599-12604, 1996.
130. Griffin, L.D. and Mellon, S.H., Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes, Proc. Natl. Acad. Sci. U.S.A., 96, 13512-13517, 1999.
131. Gyermek, L. and Soyka, L.F., Steroid anesthetics, Anesthesiology, 42, 331-344, 1975.
132. Serra, M., Madau, P., Chessa, M.F., Caddeo, M., Sanna, E., Trapani, G., Franco, M., Liso, G., Purdy, R.H., Barbaccia, M.L., and Biggio, G., 2-Phenyl-imidazo [1,2-a] pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats, Br. J. Pharmacol., 127, 177-187, 1999.
133. Okuyama, S., Chaki, S., Yoshikawa, R., Ogawa, S., Suzuki, Y., Okubo, T., Nakazato, A., Nagamine, M., and Tomisawa, K., Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106, Life Sci., 64, 1455-1464, 1999.
134. Chaki, S., Funakoshi, T., Yoshikawa, R., Okuyama, S., Okubo, T., Nakazato, A., Nagamine, M., and Tomisawa, K., Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors, Eur. J. Pharmacol., 371, 197-204, 1999.
135. Cahard, D., Canat, X., Carayon, P., Rogue, C., Casellas, P., and Le Fur, G., Subcellular localization of peripheral benzodiazepine receptors on human leukocytes, Lab. Invest., 70, 23-28, 1994.